Skip to main content
Terug
Watch Compare

Zeo ScientifiX, Inc.

Datakwaliteit: 100%
ZEOX
OTC Manufacturing Chemicals
€ 2,02
▼ € 0,06 (-2,88%)
Marktkapitalisatie: 15,71 M
Prijs
€ 2,02
Marktkapitalisatie
15,71 M
Dagbereik
€ 1,86 — € 1,97
52-Weeksbereik
€ 1,20 — € 3,32
Volume
630
Openen € 1,97
50D / 200D Gem.
€ 2,21
8,79% below
50D / 200D Gem.
€ 1,99
1,72% above

Quick Summary

Belangrijkste Punten

Revenue grew 10,89% annually over 5 years — strong growth
Negative free cash flow of -621.000,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,54%
Capital efficient — spends only 0,47% of revenue on capex

Groei

Revenue Growth (5Y)
10,89%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)1,35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-113,60%
Op. Margin-115,31%

Veiligheid

Debt / Equity
N/A
Current Ratio0,70
Interest Coverage-82,52

Waardering

PE (TTM)
-2,72
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -2,7 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -113,6 -41,5
Rev Growth 5Y % 10,9 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 1,35% Revenue Growth (3Y) -15,63%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10,89% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5,08 M Net Income (TTM) -5,77 M
ROE N/A ROA -273,36%
Gross Margin 79,89% Operating Margin -115,31%
Net Margin -113,60% Free Cash Flow (TTM) -621.000,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,70
Interest Coverage -82,52 Asset Turnover 2,41
Working Capital -879.000 Tangible Book Value -383.000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,72 Forward P/E N/A
P/B Ratio N/A P/S Ratio 3,09
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,95%
Market Cap 15,71 M Enterprise Value 15,71 M
Per Share
EPS (Diluted TTM) -0,88 Revenue / Share 0,65
FCF / Share -0,08 OCF / Share -0,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,47% FCF Conversion 10,76%
SBC-Adj. FCF -5,15 M Growth Momentum -9,54

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 4,62 M 4,56 M 6,49 M 5,60 M 3,06 M
Net Income -4,71 M -6,99 M -8,90 M -12,76 M -12,58 M
EPS (Diluted) -0,74 -0,99 — — —
Gross Profit 3,78 M 4,05 M 5,74 M 5,05 M 2,66 M
Operating Income -5,32 M -6,77 M -8,84 M -12,74 M -12,44 M
EBITDA — — — — —
R&D Expenses 164.000,0 922.700,0 791.326,0 1,12 M 233.526,0
SG&A Expenses — — — — —
D&A 74.000,0 486.354,0 332.508,0 — —
Interest Expense 92.000,0 431.424,0 398.260,0 -37.934,0 177.744,0
Income Tax — — — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 1,64 M 2,78 M 6,20 M 1,93 M 1,33 M
Total Liabilities 3,30 M 4,02 M 4,31 M 4,60 M —
Shareholders' Equity -1,65 M -1,24 M 1,89 M -2,67 M -1,39 M
Total Debt — — — — —
Cash & Equivalents — — — 108.570,0 590.797,0
Current Assets 1,17 M 2,20 M 4,37 M 517.194,0 845.783,0
Current Liabilities 3,29 M 4,01 M 4,06 M 4,13 M 2,54 M